
© 2025 wallstreetONLINE TV
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 874,40 | 875,80 | 12.02. | |
| 872,50 | 877,40 | 12.02. |

| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision | ||
| Do | ELI LILLY & Co - 10-K, Annual Report | ||
| Do | Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market | ||
| Do | Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know. | ||
| Do | Novo Nordisk said to follow Lilly and sell obesity shot Wegovy in vial |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Amid Wegovy pill's flying start in US, Novo CEO eyes Ireland expansion for supply overseas: Bloomberg | ||
| Do | Stimmungswechsel bei Novo nordisk: Diese Entwicklung macht misstrauisch - sofort handeln! | ||
| Do | Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market | ||
| Do | Novo said to eye Ireland to produce Wegovy pill for international markets | ||
| Do | Novo nordisk mit Momentum: Diese Phase nutzen Profis aus - nicht verpassen! |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ELI LILLY AND COMPANY | 875,90 | +0,10 % |
| NOVO NORDISK A/S | 41,095 | -0,18 % |